Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
18,845,409
-
Share change
-
+1,804,031
-
Total reported value
-
$149,178,103
-
Price per share
-
$10.21
-
Number of holders
-
59
-
Value change
-
+$16,034,432
-
Number of buys
-
43
-
Number of sells
-
10
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q2 2016
As of 30 Jun 2016,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,845,409 shares.
The largest 10 holders included
FMR LLC, Canaan Partners IX LLC, DEERFIELD MANAGEMENT CO, Tekla Capital Management LLC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, BVF INC/IL, VHCP Management II, LLC, BlackRock Advisors LLC, and BlackRock Fund Advisors.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.